These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22349104)

  • 41. High dose intravenous AAT and plasma neutrophil derived fibrinogen fragments.
    Stolk J; Nieuwenhuizen W; Stoller JK; Aboussouan L
    Thorax; 2005 Jan; 60(1):84; author reply 84. PubMed ID: 15618590
    [No Abstract]   [Full Text] [Related]  

  • 42. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expanding the clinical indications for α(1)-antitrypsin therapy.
    Lewis EC
    Mol Med; 2012 Sep; 18(1):957-70. PubMed ID: 22634722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha1-antitrypsin deficiency-associated panniculitis: case report and review of treatment options.
    Ortiz PG; Skov BG; Benfeldt E
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):487-90. PubMed ID: 15987301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin.
    Subramaniyam D; Virtala R; Pawłowski K; Clausen IG; Warkentin S; Stevens T; Janciauskiene S
    Int J Biochem Cell Biol; 2008; 40(2):258-71. PubMed ID: 17869162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
    Ortiz G; Salica JP; Chuluyan EH; Gallo JE
    Biol Res; 2014 Nov; 47():58. PubMed ID: 25723058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases.
    Švajger U; Jeras M
    Int Rev Immunol; 2012 Jun; 31(3):202-22. PubMed ID: 22587021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune-modulating effects of alpha-1 antitrypsin.
    Ehlers MR
    Biol Chem; 2014 Oct; 395(10):1187-93. PubMed ID: 24854541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats.
    Guttman O; Baranovski BM; Schuster R; Kaner Z; Freixo-Lima GS; Bahar N; Kalay N; Mizrahi MI; Brami I; Ochayon DE; Lewis EC
    Clin Exp Immunol; 2015 Feb; 179(2):161-72. PubMed ID: 25351931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages.
    Chan ED; Kaminska AM; Gill W; Chmura K; Feldman NE; Bai X; Floyd CM; Fulton KE; Huitt GA; Strand MJ; Iseman MD; Shapiro L
    Scand J Infect Dis; 2007; 39(8):690-6. PubMed ID: 17654345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
    Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
    J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment.
    Köhnlein T; Welte T
    Am J Med; 2008 Jan; 121(1):3-9. PubMed ID: 18187064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interference of alpha-alkyl-substituted pirinixic acid derivatives with neutrophil functions and signalling pathways.
    Poeckel D; Greiner C; Pergola C; Henkel A; Popescu L; Rau O; Schubert-Zsilavecz M; Werz O
    Eur J Pharmacol; 2009 Oct; 619(1-3):1-7. PubMed ID: 19686721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.
    Greene CM; Hassan T; Molloy K; McElvaney NG
    Expert Rev Respir Med; 2011 Jun; 5(3):395-411. PubMed ID: 21702661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Substitution therapy in alpha 1-protease inhibitor deficiency (alpha 1-antitrypsin deficiency)].
    Stössel U; Brändli O
    Schweiz Rundsch Med Prax; 1991 Nov; 80(48):1344-8. PubMed ID: 1749876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role of certain mechanisms in the pathogenesis of emphysema and a number of other lung diseases].
    Putov NV; Pokhodzeĭ IV; Kolodkina LA
    Ter Arkh; 1985; 57(3):144-8. PubMed ID: 3890255
    [No Abstract]   [Full Text] [Related]  

  • 58. A review of alpha-1 antitrypsin deficiency.
    Ranes J; Stoller JK
    Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Panniculitis in alpha-1 antitrypsin deficiency treated with enzyme replacement.
    Olson JM; Moore EC; Valasek MA; Williams LH; Vary JC
    J Am Acad Dermatol; 2012 Apr; 66(4):e139-41. PubMed ID: 22421127
    [No Abstract]   [Full Text] [Related]  

  • 60. Pregnancy in Alpha 1 Antitrypsin (AAT) Deficiency and the role of intravenous AAT therapy.
    Guarnieri G; Achille A; Lococo S; Vianello A
    Pulmonology; 2022; 28(4):317-319. PubMed ID: 35221261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.